Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

SAGE Stock Annual Income Statement. Download in Excel

Sage Therapeutics Inc. logo

Sage Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

9.30
 
USD
  
0.17
  
(1.86%)
Previous close: 9.13  Open: 9.19  Bid: 9.11  Ask: 9.3
52 week range    
4.62   
   13.47
Mkt Cap: 571 M  Avg Vol (90 Days): 1,523,962
Last updated: Sunday 22nd June 2025

Stock Rankings

61
MarketXLS Rank
60
Value
83
Technical
42
Quality
How are these ranks calculated?
Search for a stock

Financials

SAGE Income Statement

Annual
Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23Dec-24
Basic EPS from continuing operations-13.3811.66-7.8-8.98-9.05-6.59
Basic EPS total-13.3811.66-7.8-8.98-9.05-6.59
Basic weighted shares outstanding28 M33 M38 M46 M51 M52 M59 M59 M60 M61 M
Cost of sales565000.0813000.0
Depreciation-100000.0-300000.0-500000.0-1 M2 M3 M4 M1 M1 M1 M
DepreciationAndAmortization-100000.0-300000.0-500000.0-1 M2 M3 M4 M1 M1 M1 M
Diluted EPS total-3.4-4.75-7.09-8.08-13.3811.43-7.8-8.98-9.05-6.59
Diluted normalized net income/share11.43-7.8-8.98-9.05-6.59
Diluted weighted shares outstanding28 M33 M38 M46 M51 M53 M59 M59 M60 M61 M
GainOnSaleOfSecurity-102000.0
GeneralAndAdministrativeExpense25 M39 M63 M-6 M346 M197 M183 M228 M275 M216 M
Gross operating profit90 M7 M1,114 M6 M7 M86 M41 M
Income before tax-94 M-159 M-270 M-373 M-679 M607 M-457 M-533 M-539 M-391 M
Income restructuring and M&A28 M33 M22 M
Interest income178000.01 M3 M20 M28 M10 M3 M14 M39 M32 M
MiscOtherSpecialCharges-23000.0-35000.0-64000.022000.082000.0250000.0134000.015000.0-383000.029000.0
Net income from total operations-94 M-159 M-270 M-373 M-680 M606 M-458 M-533 M-541 M-401 M
NetIncomeCommonStockholders-94 M-159 M-270 M-373 M-679 M606 M-458 M-533 M-541 M-401 M
NetIncomeContinuousOperations-94 M-159 M-270 M-373 M-680 M606 M-458 M-533 M-541 M-401 M
NetNonOperatingInterestIncomeExpense178000.01 M3 M20 M28 M10 M3 M14 M39 M32 M
Normalized income-363 M
Operating income-95 M-160 M-273 M-393 M-708 M596 M-461 M-547 M-580 M-432 M
Operating income before depreciation (EBITDA)-94 M-159 M-270 M-372 M-677 M627 M-453 M-532 M-540 M-400 M
OperatingExpense-95 M-160 M-273 M-484 M715 M518 M467 M554 M666 M474 M
Other income net23000.035000.064000.0-22000.0-82000.0-250000.0-134000.015000.0383000.0-29000.0
OtherGandA25 M39 M63 M-6 M346 M197 M183 M228 M275 M216 M
OtherImpairmentOfCapitalAssets2 M
OtherOperatingExpenses-95 M-160 M-273 M-484 M-400000.0-565000.0-553000.0-697000.0-655000.0-520000.0
RentAndLandingFees25 M39 M63 M-6 M10 M
Research & development expense69 M121 M210 M282 M369 M293 M283 M326 M356 M226 M
ResearchExpense69 M121 M210 M282 M369 M293 M283 M326 M356 M226 M
RestructringAndMnAIncome28 M33 M22 M
SalariesAndWages-15 M-23 M-36 M-102 M62 M73 M55 M
Selling Gen & administrative expense25 M39 M63 M201 M346 M197 M183 M228 M275 M216 M
SellingAndMarketingExpense201 M
SellingExpense201 M
Special income/charges-28 M-33 M-22 M
Total Income available for interest expense (EBIT)-94 M-159 M-270 M-373 M-679 M624 M-457 M-533 M-541 M-401 M
Total common shares outstanding32 M37 M46 M47 M52 M58 M59 M60 M60 M61 M
Total net income-94 M-159 M-270 M-373 M-680 M606 M-458 M-533 M-541 M-401 M
Total ordinary shares63 M63 M63 M63 M63 M63 M63 M63 M63 M63 M
Total revenues90 M7 M1,114 M6 M8 M86 M41 M
TotalExpenses-95 M-160 M-273 M-484 M715 M518 M467 M555 M666 M474 M
TotalRevenue90 M7 M1,114 M6 M8 M86 M41 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader